The predictive value of MAPH score for determining thrombus burden in patients with non-ST segment elevation

Özge Çakmak Karaaslan1, Cem Çöteli2, Murat Oğuz Özilhan3

  • 1Department of Cardiology, Ankara Bilkent City Hospital, Health Sciences University, Ankara, Turkey. ozgecakmak2323@gmail.com.

Insights

The MAPH score, using mean platelet volume, age, total protein, and hematocrit, effectively predicts high thrombus burden in non-ST segment elevation myocardial infarction (NSTEMI) patients. This accessible score aids in assessing cardiovascular risk.

Area of Science:

  • Cardiology
  • Hematology
  • Biomedical Engineering

Background:

  • High thrombus burden is linked to adverse outcomes in non-ST segment elevation myocardial infarction (NSTEMI).
  • The MAPH score's predictive value for thrombus burden in NSTEMI is not well-established.
  • This study investigates the MAPH score's prognostic role in estimating coronary thrombus burden in NSTEMI patients.

Purpose of the Study:

  • To evaluate the prognostic role of the MAPH score in estimating coronary thrombus burden in NSTEMI patients.
  • To determine if the MAPH score can predict high thrombus burden (HTB) in NSTEMI.
  • To assess the relationship between MAPH score, low shear rate (LSR), and high shear rate (HSR) with thrombus burden.

Main Methods:

  • Patients were categorized into low and high thrombus burden groups.
  • Low shear rate (LSR) and high shear rate (HSR) were estimated using hematocrit and serum total protein levels.
  • The MAPH score was calculated by summing mean platelet volume (MPV), age, total protein, and hematocrit.

Main Results:

  • Patients with high thrombus burden exhibited higher LSR, HSR, and MAPH scores.
  • The MAPH score independently predicted high thrombus burden in both adjusted models (Model 1: OR 1.124; Model 2: OR 1.236).
  • A MAPH score cutoff of 2 was identified for predicting high thrombus burden.

Conclusions:

  • The MAPH score, incorporating MPV, age, total protein, and hematocrit, is a novel and accessible predictor.
  • The MAPH score is an independent predictor of high thrombus burden in NSTEMI patients under both LSR and HSR conditions.
Abstract